HIMS stock is taking a nose dive after Novo Nordisk announces its collaboration with Hims & Hers is being terminated. This is due to allegations that Hims & Hers failed to comply with laws prohibiting mass sales of compounded drugs, putting the public safety at risk.
https://www.investing.com/news/stock-market...
Hims & Hers Health
HIMS
trading on NYSE
since 2021
$42.90
(Δ 2.17%
)
+$0.91
since open
Hims & Hers Health provides telehealth and digital health services, offering primary care, mental health, and other medical consultations through an accessible online platform.
type | open | high | low |
market cap |
volume |
---|---|---|---|---|---|
stock | $48.16 | $48.35 | $41.97 | $13.38B | 176.09M |
eps | p/e | p/s |
operating margin |
profit margin |
yield |
+$0.22 | 68.10 | 18.05 | 9.88% | 8.44% | 0% |